"Malaria, Falciparum" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations.
| Descriptor ID |
D016778
|
| MeSH Number(s) |
C03.752.530.650
|
| Concept/Terms |
Malaria, Falciparum- Malaria, Falciparum
- Plasmodium falciparum Malaria
- Malaria, Plasmodium falciparum
|
Below are MeSH descriptors whose meaning is more general than "Malaria, Falciparum".
Below are MeSH descriptors whose meaning is more specific than "Malaria, Falciparum".
This graph shows the total number of publications written about "Malaria, Falciparum" by people in this website by year, and whether "Malaria, Falciparum" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2002 | 3 | 0 | 3 |
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 1 | 3 |
| 2013 | 1 | 1 | 2 |
| 2014 | 4 | 0 | 4 |
| 2015 | 3 | 0 | 3 |
| 2016 | 3 | 1 | 4 |
| 2017 | 3 | 1 | 4 |
| 2018 | 2 | 1 | 3 |
| 2019 | 3 | 1 | 4 |
| 2020 | 4 | 0 | 4 |
| 2021 | 3 | 2 | 5 |
| 2022 | 6 | 0 | 6 |
| 2023 | 2 | 0 | 2 |
| 2024 | 2 | 0 | 2 |
| 2025 | 0 | 2 | 2 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Malaria, Falciparum" by people in Profiles.
-
Helminth coinfections mitigate clinical, parasitological, and immune outcomes in Mozambican children with malaria. BMC Med. 2026 Mar 31; 24(1).
-
Fc?R binding differentially contributes to protection by two human monoclonal antibodies targeting Plasmodium falciparum circumsporozoite protein. Sci Transl Med. 2025 Apr 23; 17(795):eadk6745.
-
Differential ex vivo susceptibility of Plasmodium malariae and Plasmodium falciparum clinical isolates from Ghana and Mali to current and lead discovery candidate antimalarial drugs. Microbiol Spectr. 2025 Apr; 13(4):e0217624.
-
A kalihinol analog disrupts apicoplast function and vesicular trafficking in P. falciparum malaria. Science. 2024 09 27; 385(6716):eadm7966.
-
Using serological diagnostics to characterize remaining high-incidence pockets of malaria in forest-fringe Cambodia. Malar J. 2024 Feb 15; 23(1):49.
-
Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana. Microbiol Spectr. 2023 06 15; 11(3):e0491622.
-
Identification of novel Plasmodium vivax proteins associated with protection against clinical malaria. Front Cell Infect Microbiol. 2023; 13:1076150.
-
Co-infection of the four major Plasmodium species: Effects on densities and gametocyte carriage. PLoS Negl Trop Dis. 2022 09; 16(9):e0010760.
-
Assessment of IgG3 as a serological exposure marker for Plasmodium vivax in areas with moderate-high malaria transmission intensity. Front Cell Infect Microbiol. 2022; 12:950909.
-
Spatial distribution of incident pediatric Burkitt lymphoma in central and northern Malawi and association with malaria prevalence. Pediatr Blood Cancer. 2022 10; 69(10):e29867.